Chengzhi Li

机构：First Affiliated Hospital of Jinan University · ORCID：0000-0002-6661-166X

发表论文 21 篇 · 总被引 162 次 · h-index 9

代表论文

• A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy (2023 · La radiologia medica · 被引 34)
• Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis (2024 · Hepatology International · 被引 16)
• Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma (2024 · Materials Today Bio · 被引 14)
• Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning (2024 · European Radiology · 被引 14)
• Multiparametric MRI‐based model for prediction of local progression of hepatocellular carcinoma after thermal ablation (2023 · Cancer Medicine · 被引 14)
• Efficacy and safety of HAIC alone vs. HAIC combined with lenvatinib for treatment of advanced hepatocellular carcinoma (2023 · Medical Oncology · 被引 14)